Revenue: The sum of all revenue fields included for a company's operating activities.
Grace Therapeutics, Inc. (GRCE) Revenue data is not available for the most recently reported fiscal year, ending 2024-03-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-12.85M |
|
-- |
|
-- |
|
$12.85M |
|
$-12.85M |
|
$-1.83M |
|
$-14.69M |
|
$-14.69M |
|
$-12.85M |
|
$-12.85M |
|
$-12.85M |
|
$-12.85M |
|
$-12.85M |
|
$-12.84M |
|
9.53M |
|
9.53M |
|
$-1.35 |
|
$-1.35 |
|
| Balance Sheet Financials | |
$24.01M |
|
$0.02M |
|
$49.29M |
|
$73.30M |
|
$1.68M |
|
-- |
|
$9.87M |
|
$11.56M |
|
$61.74M |
|
$12.48M |
|
$61.74M |
|
9.40M |
|
| Cash Flow Statement Financials | |
$-12.33M |
|
$0.10M |
|
$7.36M |
|
$27.88M |
|
$23.00M |
|
$-4.87M |
|
$0.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.26 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.24M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-20.82% |
|
-103.01% |
|
-17.53% |
|
-20.82% |
|
$6.57 |
|
$-1.28 |
|
$-1.29 |
|